HomeRX • CVE
add
Biosyent Inc
Previous close
$11.15
Day range
$11.05 - $11.20
Year range
$9.20 - $12.49
Market cap
128.39M CAD
Avg Volume
4.84K
P/E ratio
15.78
Dividend yield
1.79%
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 10.18M | 13.80% |
Operating expense | 5.37M | 4.29% |
Net income | 2.02M | 27.71% |
Net profit margin | 19.83 | 12.22% |
Earnings per share | — | — |
EBITDA | 2.67M | 30.14% |
Effective tax rate | 26.50% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.36M | 16.98% |
Total assets | 43.50M | 4.86% |
Total liabilities | 5.89M | -2.73% |
Total equity | 37.60M | — |
Shares outstanding | 11.26M | — |
Price to book | 3.34 | — |
Return on assets | 14.77% | — |
Return on capital | 16.86% | — |
Cash Flow
Net change in cash
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 2.02M | 27.71% |
Cash from operations | 3.47M | 329.82% |
Cash from investing | 171.69K | -97.60% |
Cash from financing | -640.57K | 29.86% |
Net change in cash | 3.00M | -36.75% |
Free cash flow | 2.13M | 241.73% |
About
Founded
1947
Headquarters
Website
